Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Church

Showing results (41-50 of 328) with videos related to

Pageof 33
Sort By:
Journal of Children'S Orthopaedics|May 1, 2018
Patient-reported mobility function and engagement in young adults with cerebral palsy: a cross-sectional sampleN Lennon, C Church, F Miller
The Journal of Biological Chemistry|November 27, 1999
Enhancement of heparin cofactor II anticoagulant activityS J Bauman, F C Church
Archives of Biochemistry and Biophysics|March 21, 2003
Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in bloodHaifeng M Wu, Frank C Church
Trends in Cardiovascular Medicine|January 20, 2011
Heparin cofactor II and thrombin Heparin-binding proteins linking hemostasis and inflammationF C Church, M R Hoffman
PPAR Research|August 13, 2009
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Jennifer C Carter, Frank C Church
Journal of Animal Science|July 1, 1980
Digestibility of untreated and hydroxide-treated annual ryegrass strawD C Church, K A Champe
The Journal of the Acoustical Society of America|February 2, 2023
Introduction to the Special Issue on COVID-19James F Lynch, Charles C Church
Biochimica Et Biophysica Acta|January 5, 1995
Reactive site mutants of recombinant protein C inhibitorS T Cooper, F C Church
The Journal of Biological Chemistry|February 22, 2002
Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibitionJennifer W Mitchell, Frank C Church
Progress in Biophysics and Molecular Biology|September 5, 2006
Quantification of risk from fetal exposure to diagnostic ultrasoundCharles C Church, Morton W Miller
Pageof 33

Showing results (41-50 of 328) with videos related to

Sort By:
Pageof 33
Journal of Children'S Orthopaedics|May 1, 2018
Patient-reported mobility function and engagement in young adults with cerebral palsy: a cross-sectional sampleN Lennon, C Church, F Miller
The Journal of Biological Chemistry|November 27, 1999
Enhancement of heparin cofactor II anticoagulant activityS J Bauman, F C Church
Archives of Biochemistry and Biophysics|March 21, 2003
Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in bloodHaifeng M Wu, Frank C Church
Trends in Cardiovascular Medicine|January 20, 2011
Heparin cofactor II and thrombin Heparin-binding proteins linking hemostasis and inflammationF C Church, M R Hoffman
PPAR Research|August 13, 2009
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Jennifer C Carter, Frank C Church
Journal of Animal Science|July 1, 1980
Digestibility of untreated and hydroxide-treated annual ryegrass strawD C Church, K A Champe
The Journal of the Acoustical Society of America|February 2, 2023
Introduction to the Special Issue on COVID-19James F Lynch, Charles C Church
Biochimica Et Biophysica Acta|January 5, 1995
Reactive site mutants of recombinant protein C inhibitorS T Cooper, F C Church
The Journal of Biological Chemistry|February 22, 2002
Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibitionJennifer W Mitchell, Frank C Church
Progress in Biophysics and Molecular Biology|September 5, 2006
Quantification of risk from fetal exposure to diagnostic ultrasoundCharles C Church, Morton W Miller
Pageof 33